Product Information
AMLODIPINE-BENAZEPRIL 2.5-10 is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1013 per EA under NDC 57237014201. Its NADAC has been published 550 times since Feb 10, 2016.
FDA first approved this application on Sep 5, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5; 10 mg/1; mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237014201
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202239FDA Approved
9/5/2012
TE Code
AB
On Market Since
9/5/2012
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-BENAZEPRIL 2.5-10 has been published 550 times since Feb 10, 2016, and over the history we have for it it has declined 82.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1013 per EA |
|---|---|
| All-time high | $0.6031 (Aug 10, 2016) |
| All-time low | $0.0735 (Apr 17, 2024) |
| 52-week high | $0.1061 |
| 52-week low | $0.0930 |
| Median price | $0.1450 |
| Average price | $0.1855 |
| Largest weekly change | +58.1% (Sep 19, 2018) |
| Weeks tracked | 550 |
| Tracking since | Feb 10, 2016 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMLODIPINE-BENAZEPRIL 2.5-10?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-BENAZEPRIL 2.5-10, manufactured by Rising Pharma Holdings Inc., is $0.1013 per EA (NDC 57237014201), effective Aug 19, 2026.
How has the price of AMLODIPINE-BENAZEPRIL 2.5-10 changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-BENAZEPRIL 2.5-10 has declined 82.4%. It has been tracked across 550 weekly CMS publications since Feb 10, 2016.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-BENAZEPRIL 2.5-10?
Since Feb 10, 2016, the NADAC for AMLODIPINE-BENAZEPRIL 2.5-10 has ranged from a low of $0.0735 (Apr 17, 2024) to a high of $0.6031 (Aug 10, 2016), with a median of $0.1450 per EA.
Are there cheaper alternatives to AMLODIPINE-BENAZEPRIL 2.5-10?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-BENAZEPRIL 2.5-10 in a comparable dosage form, but none are currently priced below it.
Who manufactures AMLODIPINE-BENAZEPRIL 2.5-10?
AMLODIPINE-BENAZEPRIL 2.5-10 (NDC 57237014201) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.